Revenue and Profit - Revenue for Q3 2025 reached ¥178,934,849.98, an increase of 27.12% year-over-year, and total revenue for the year-to-date is ¥499,623,261.57, up 36.97%[5] - Net profit attributable to shareholders for Q3 2025 was ¥29,459,201.23, a 59.13% increase compared to the same period last year, with year-to-date net profit at ¥75,432,366.11, up 41.75%[5] - The net profit after deducting non-recurring gains and losses for Q3 2025 was ¥25,868,043.86, reflecting a 72.14% increase year-over-year, while year-to-date figures reached ¥69,352,611.13, up 59.97%[5] - Revenue for the first nine months of 2025 reached ¥499,623,261.57, a year-on-year increase of 36.97% primarily due to increased sales of power forecasting products[11] - The company reported total operating revenue of ¥499,623,261.57 for the current period, an increase of 37% compared to ¥364,781,559.92 in the previous period[25] - The total profit before tax was 88,472,044.18, an increase from 62,138,878.78, representing a growth of approximately 42.3%[26] - The company recognized investment income of 8,866,289.14 from associates and joint ventures, up from 4,807,587.33, reflecting an increase of about 84.8%[26] Assets and Equity - The company's total assets as of September 30, 2025, amounted to ¥2,372,433,693.14, representing a 32.27% increase from the end of the previous year[5] - Shareholders' equity attributable to the parent company increased to ¥1,529,182,275.83, a rise of 32.13% compared to the end of the previous year[5] - The company's total assets increased to ¥2,372,433,693.14 from ¥1,793,657,818.57, showing a growth of approximately 32%[22] - The company's equity attributable to shareholders increased to ¥1,529,182,275.83 from ¥1,157,309,345.83, marking a growth of approximately 32%[23] Cash Flow - Cash flow from operating activities for the year-to-date is ¥48,243,402.89, showing a significant increase of 213.95%[5] - Net cash flow from operating activities improved significantly to ¥48,243,402.89, a 213.95% increase compared to a net outflow of ¥42,335,903.83 in the same period last year[14] - The net cash flow from operating activities improved to 48,243,402.89, a significant recovery from a negative cash flow of -42,335,903.83 in the previous period[28] - The net cash flow from investing activities was -588,524,976.95, worsening from -196,502,919.51 in the previous period, indicating increased investment outflows[29] - The net cash flow from financing activities improved to 301,684,500.35, compared to -7,190,783.11 in the previous period, showing a positive turnaround[29] Costs and Expenses - Operating costs rose to ¥194,718,967.51, reflecting a 63.16% increase attributed to higher costs associated with power forecasting products[11] - Total operating costs amounted to ¥418,715,263.46, up from ¥312,962,848.48, reflecting a significant increase in operational expenses[25] - The company reported a significant increase in financial expenses, totaling ¥8,906,484.60, a 417.02% rise due to reduced bank interest income and increased interest expenses from financial leasing and bank loans[11] - Research and development expenses were ¥68,072,612.97, compared to ¥64,766,469.39 in the previous period, indicating a continued investment in innovation[25] Investments - The company reported a 215.96% increase in trading financial assets, totaling ¥443,772,611.70, primarily due to increased investments in structured deposits and low-risk financial products[9] - Long-term equity investments rose by 144.77% to ¥228,957,448.84, attributed to increased external equity investments[9] - The company completed a private placement of 12,362,068 shares, raising a total of ¥377,661,177.40, which will enhance its capital base[18] - The company acquired a 25% stake in Tibet Dongrun Digital Energy Co., Ltd. through investments totaling ¥10,503.33 million, indicating strategic expansion efforts[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,073, with the largest shareholder holding 33.55% of the shares[15] Other Financial Metrics - The weighted average return on net assets for Q3 2025 was 2.08%, an increase of 0.42% year-over-year, while the year-to-date figure is 5.99%, up 1.13%[5] - The company recorded a 268.72% increase in non-operating income, amounting to ¥161,240.18, primarily from increased compensation for breach of contract[12] - The fair value change income decreased by 58.00% to ¥2,587,273.43, mainly due to reduced fair value changes related to bank wealth management products during the reporting period[11] - Basic and diluted earnings per share both increased to 0.61, compared to 0.44 in the previous period, marking a rise of 38.6%[27] - The total cash and cash equivalents decreased to ¥265,298,565.46 from ¥501,858,731.88, reflecting a reduction in liquidity[21] - The company's total non-current assets increased to ¥977,297,922.06 from ¥603,921,618.72, indicating a focus on long-term investments[22]

Financial Performance - Q3 2025 revenue was CNY 1,625,476,998.14, a decrease of 17.28% year-over-year, and year-to-date revenue was CNY 5,478,085,124.55, down 10.69%[5] - Net profit attributable to shareholders for Q3 2025 was CNY 43,524,470.78, a decline of 14.92% year-over-year, with year-to-date net profit at CNY 172,703,081.21, down 16.96%[5] - Total operating revenue for the current period is ¥5,478,085,124.55, a decrease of 10.7% from ¥6,133,512,515.79 in the previous period[33] - Net profit for the current period is ¥161,044,610.95, a decline of 26.8% compared to ¥220,053,562.43 in the previous period[34] - Earnings per share for the current period is ¥0.1209, down from ¥0.1455 in the previous period[35] Research and Development - R&D expenses for the period amounted to CNY 10,396,000, representing a significant increase of 95% compared to the same period last year[16] - Research and development expenses increased to ¥103,963,842.54, up from ¥53,424,342.80 in the previous period, indicating a focus on innovation[34] - The company received approval for clinical trials of DCTY0801 injection, marking a significant milestone in product development[27] - The company aims to enhance its core competitiveness in the oncology treatment field through accelerated product development[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 13,648,603,462.73, a decrease of 5.52% from the end of the previous year[5] - Total liabilities amount to ¥8,051,463,190.34, a decrease from ¥8,876,538,951.68 in the previous period[34] - The company’s total assets amount to ¥13,648,603,462.73, down from ¥14,446,181,851.25 in the previous period[34] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 379,202,723.95, a decrease of 11.52%[5] - The net cash inflow from operating activities was CNY 379,202,723.95, a decrease of 11.5% compared to CNY 428,565,749.88 in the previous period[37] - Total cash inflow from financing activities was CNY 9,351,477,799.16, down from CNY 11,004,407,687.50, reflecting a decrease of 15%[38] - The net cash outflow from investment activities was CNY -74,420,303.54, compared to CNY -135,729,071.37 in the previous period, indicating an improvement[37] - Cash received from other operating activities was CNY 173,056,766.13, compared to CNY 223,851,078.74, showing a decline of 22.7%[37] Shareholder Information - Total number of common shareholders at the end of the reporting period is 49,696[26] - Jiangxi Fangda Steel holds 32.08% of shares, totaling 457,861,342 shares[26] - Liaoning Fangda Group holds 23.60% of shares, totaling 329,068,713 shares[26] Inventory and Receivables - Accounts receivable increased to approximately ¥2.25 billion from ¥1.96 billion[30] - Inventory decreased to approximately ¥1.14 billion from ¥1.32 billion[30] - The company's cash and cash equivalents decreased to approximately ¥4.08 billion from ¥4.47 billion[29] Cost Management - Total operating costs for the current period are ¥5,196,594,704.99, down 10.1% from ¥5,783,158,351.88 in the previous period[34] - The company reported a decrease in sales expenses to ¥879,243,019.69 from ¥1,047,384,162.17 in the previous period, reflecting cost control measures[34] - Cash paid for purchasing goods and services was CNY 2,969,341,549.87, down from CNY 3,534,534,806.96, a decrease of 16%[37]

许继电气股份有限公司 2025 年第三季度报告 证券代码：000400 证券简称：许继电气 公告编号：2025-45 许继电气股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度 报告中财务信息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 适用 □不适用 单位：元 1 许继电气股份有限公司 2025 年第三季度报告 | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益（包括已计提资产减值 | -1,172,171.82 | -2,696,718.20 | | | 准备的冲销部分） | | | | | 计入当期损益的政府补助（与公司正常经营业 务密切相关、符合 ...

Financial Performance - Revenue for Q3 2025 reached CNY 439.46 million, an increase of 28.80% year-over-year[4] - Total profit for Q3 2025 was CNY 57.88 million, reflecting a growth of 5.79% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2025 was CNY 46.87 million, up 5.78% year-over-year[4] - Year-to-date revenue as of Q3 2025 was CNY 1.12 billion, representing a 17.67% increase from the previous year[4] - Year-to-date net profit attributable to shareholders reached CNY 95.93 million, a significant increase of 51.66% compared to the same period last year[4] - The basic earnings per share for Q3 2025 was CNY 0.21, a 5.00% increase from the previous quarter[6] - The diluted earnings per share for Q3 2025 was CNY 0.20, reflecting a 5.26% increase from the previous quarter[6] - Total operating revenue for the first three quarters of 2025 reached ¥1,116,793,584.58, an increase of 17.7% compared to ¥949,078,888.15 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was ¥101,141,381.38, representing a 49.3% increase from ¥67,712,359.44 in 2024[20] - Earnings per share for the first three quarters of 2025 were ¥0.43, compared to ¥0.29 in the same period of 2024[20] - The total comprehensive income for the first three quarters of 2025 was ¥101,270,325.50, compared to ¥67,882,973.44 in 2024, indicating a growth of 48.9%[20] Cash Flow - The cash flow from operating activities for the year-to-date period decreased by 55.66% to CNY 31.93 million due to increased procurement costs[10] - The cash inflow from operating activities for the first three quarters of 2025 was CNY 1,182,691,449.93, an increase of 5.0% compared to CNY 1,125,620,482.17 in the same period of 2024[23] - The net cash flow from operating activities decreased to CNY 31,925,429.36 in 2025, down 55.6% from CNY 71,996,591.12 in 2024[23] - The cash inflow from investment activities totaled CNY 535,571,542.41, up 7.4% from CNY 498,559,927.67 in the previous year[24] - The net cash flow from investment activities was negative at CNY -47,309,692.86, an improvement from CNY -84,071,680.68 in 2024[24] - The cash inflow from financing activities increased to CNY 830,637,979.13, compared to CNY 760,134,748.59 in the same period last year, marking a growth of 9.2%[24] - The net cash flow from financing activities decreased to CNY 15,127,252.41, down 55.8% from CNY 34,162,461.02 in 2024[24] - The total cash outflow for operating activities was CNY 1,150,766,020.57, an increase of 9.2% from CNY 1,053,623,891.05 in the previous year[23] - The company received CNY 70,733,475.25 in tax refunds, a decrease of 7.3% from CNY 76,293,106.22 in 2024[23] - The company reported a total cash outflow for investment activities of CNY 582,881,235.27, which was relatively stable compared to CNY 582,631,608.35 in the previous year[24] Assets and Liabilities - The total assets as of the end of Q3 2025 were CNY 4.75 billion, a 2.08% increase from the end of the previous year[6] - The company's total current assets as of September 30, 2025, amount to ¥2,074,208,973.95, an increase from ¥1,971,456,075.31 as of December 31, 2024[15] - Total assets as of September 30, 2025, are ¥4,748,162,999.72, compared to ¥4,651,221,247.28 at the end of 2024[15] - The company's total liabilities decreased to ¥2,329,036,956.23 in 2025 from ¥2,359,778,651.01 in 2024, a reduction of approximately 1.3%[17] - Total equity attributable to shareholders increased to ¥2,314,743,224.46 in 2025 from ¥2,192,744,591.54 in 2024, reflecting a growth of about 5.6%[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 34,704[12] - The largest shareholder, Ningbo Meinuohua Holding Group Co., Ltd., holds 45,285,661 shares, representing 20.53% of total shares[12] - The company has a total of 12,070,253 shares held by individual shareholder Yao Chengzhi, representing 5.47%[12] - The company has no significant changes in the shareholding structure or any major new strategies reported during the period[13] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥64,306,170.45, slightly down from ¥64,469,834.54 in 2024[19] - The company reported an investment income of ¥8,933,777.64 in 2025, a significant recovery from a loss of ¥25,977,207.38 in 2024[19] Inventory and Borrowings - Inventory has increased to ¥915,673,142.37 from ¥773,762,417.23 year-over-year[15] - Short-term borrowings have risen to ¥545,184,048.34 from ¥479,056,993.19 year-over-year[15] - The total non-current assets are ¥2,673,954,025.77, a slight decrease from ¥2,679,765,171.97[15]

Financial Performance - Q3 2025 revenue was CNY 461,341,934.15, a decrease of 19.12% year-over-year[5] - Total operating revenue for the period was CNY 1,498,096,674.14, a decrease of 12.1% compared to CNY 1,704,913,267.40 in the previous period[18] - Net profit for the period reached CNY 37,618,509.31, an increase of 12.1% compared to CNY 33,569,568.47 in the previous period[19] - Total comprehensive income for the period reached ¥37,618,509.31, an increase from ¥33,569,568.47 in the previous period, representing a growth of approximately 6.1%[20] - Basic and diluted earnings per share increased to ¥0.10 from ¥0.09, reflecting a growth of 11.1%[20] Profitability and Costs - Net profit attributable to shareholders was CNY 9,983,113.29, an increase of 23.42% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was CNY 8,349,056.56, up 38.90% year-over-year[5] - Total operating costs amounted to CNY 1,451,159,668.22, down 12.3% from CNY 1,655,377,737.29 in the prior period[18] - Research and development expenses were CNY 50,228,461.51, down 9.1% from CNY 55,501,707.86 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,110,302,988.10, down 7.86% from the end of the previous year[5] - The company's total assets decreased to CNY 3,110,302,988.10 from CNY 3,375,622,672.06, reflecting a decline of 7.9%[16] - Current assets totaled CNY 2,016,271,530.37, down 12.7% from CNY 2,309,051,155.23 at the beginning of the period[15] - The total liabilities decreased to CNY 936,229,524.23 from CNY 1,214,994,350.59, a reduction of 22.8%[16] - The company's equity attributable to shareholders increased to CNY 2,131,862,764.65 from CNY 2,114,575,761.47, reflecting a growth of 0.8%[16] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 254,383,922.36, an increase of 21.77%[5] - Net cash flow from operating activities was ¥254,383,922.36, up from ¥208,899,590.49, indicating an increase of about 21.8%[22] - Cash inflow from operating activities decreased to ¥1,663,133,408.66 from ¥1,825,911,195.55, a decline of about 8.9%[21] - Cash outflow from operating activities also decreased to ¥1,408,749,486.30 from ¥1,617,011,605.06, a reduction of approximately 13.0%[22] - The company reported a net increase in cash and cash equivalents of ¥149,525,065.69, compared to ¥96,523,476.04 in the previous period, representing an increase of approximately 55.0%[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 31,566[10] - The largest shareholder, Longi Group Co., Ltd., holds 42.16% of the shares[10] Inventory and Receivables - The company experienced a 49.13% increase in notes receivable compared to the beginning of the period[11] - Inventory decreased by 32.26% compared to the beginning of the period, indicating reduced stock levels[11] - Accounts receivable fell to CNY 401,401,100.11 from CNY 555,141,999.24, a decline of 27.7%[14] - Inventory decreased significantly to CNY 320,757,524.15, a drop of 32.2% from CNY 473,519,078.03[15] Audit Status - The financial report for the third quarter was not audited, indicating a need for caution in interpreting the results[24]

北京盈建科软件股份有限公司 2025 年第三季度报告 证券代码：300935 证券简称：盈建科 公告编号：2025-023 北京盈建科软件股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示： 北京盈建科软件股份有限公司 2025 年第三季度报告 一、主要财务数据 （一）主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 24,135,170.75 | -0.76% | 72,584,125.00 | -3.02% | | 归属于上市公司股东的净利润（元） | -15,024,321.36 | -14.30% | -47,400,671.75 | -25.83% | | 归属于上市公司股东的扣除非经常性损益 的净利润（元） | -17,212,194.25 | -5.51% ...

苏州市建筑科学研究院集团股份有限公司 2025 年第三季度报告 证券代码：603183 证券简称：建研院 苏州市建筑科学研究院集团股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 183,232,493.92 ...

Financial Performance - The company's operating revenue for the third quarter was ¥100,825,191.52, a decrease of 15.75% compared to the same period last year[4] - The total profit for the quarter was -¥3,541,675.38, with a year-to-date profit of ¥786,597.84, reflecting a significant decline of 96.13% year-on-year[4] - The net profit attributable to shareholders was -¥2,555,103.91 for the quarter, down 91.08% year-to-date compared to ¥1,678,138.49[4] - The basic earnings per share for the quarter was -¥0.01, a decrease of 83.33% compared to the previous year[4] - Total operating revenue for the first three quarters of 2025 was CNY 279,657,582.58, a decrease of 6.1% compared to CNY 298,239,254.62 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was CNY 774,052.57, a significant decline from CNY 19,112,078.45 in the same period of 2024[21] - Basic earnings per share for the first three quarters of 2025 were CNY 0.01, down from CNY 0.06 in 2024[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,214,217,515.92, a decrease of 2.14% from the end of the previous year[5] - Total current assets as of September 30, 2025, amount to ¥843,753,083.49, a slight decrease from ¥853,110,064.28 as of December 31, 2024[16] - Total liabilities decreased to ¥118,794,993.39 from ¥146,080,040.06[17] - The total liabilities and equity amounted to CNY 1,214,217,515.92, a decrease from CNY 1,240,728,510.02 in the previous year[18] - The company’s total equity attributable to shareholders was CNY 1,168,429,174.22, showing a slight increase from CNY 1,166,751,035.73[18] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥30,549,279.37, indicating an increase due to improved sales collections and reduced material procurement expenses[11] - The company reported a net cash flow from operating activities of CNY 30,549,279.37, compared to a negative cash flow of CNY -1,281,036.08 in the previous year[23] - Net cash flow from investing activities was -$103.45 million, a decrease from -$200.51 million year-over-year[24] - The net increase in cash and cash equivalents was -$69.87 million, compared to -$186.55 million year-over-year[24] - The ending balance of cash and cash equivalents was $192.40 million, down from $271.69 million in the previous period[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 20,244[13] - The largest shareholder, Liaoning Times Wan Heng Holding Group Co., Ltd., holds 143,133,473 shares, accounting for 48.63% of total shares[13] Operational Insights - The decline in profits was primarily attributed to decreased sales prices from major customers in the lithium battery industry, leading to a drop in gross margins[10] - The company plans to continue focusing on cost management and exploring new market opportunities to improve financial performance in the upcoming quarters[10] - The company reported non-recurring gains of ¥402,535.32 for the quarter, with significant contributions from government subsidies and financial asset disposals[8] - The company reported a credit impairment loss of CNY 5,632,305.72, compared to a gain of CNY -4,735,912.95 in the previous year[21] Investment and R&D - Research and development expenses for the first three quarters of 2025 were CNY 18,803,004.70, slightly down from CNY 19,681,963.53 in 2024[20] - The company achieved an investment income of CNY 1,217,315.66, compared to CNY 625,808.70 in the same period last year, reflecting a 94.5% increase[20] Other Information - The company has no significant changes in the top 10 shareholders due to margin trading activities[14] - The company has not reported any new strategies or product developments during the reporting period[15] - The company will not apply new accounting standards starting from 2025[25]

公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整 浙江新中港热电股份有限公司 2025 年第三季度报告 证券代码：605162 证券简称：新中港 转债代码：111013 转债简称：新港转债 浙江新中港热电股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 期末比上年 | | | | 减变动幅度 | | 同期增减变 | | | | (%) | | 动幅度(%) | | 营业收入 | 164,368,503 ...

新疆百花村医药集团股份有限公司 证券代码：600721 证券简称：百花医药 新疆百花村医药集团股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误导性陈 述或重大遗漏，并承担个别和连带的法律责任。 公司负责人郑彩红、主管会计工作负责人蔡子云及会计机构负责人（会计主管人员）余涛保证季度报告 中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 1 / 10 单位：元 币种：人民币 项目 本报告期 本报告期比上年同 期增减变动幅度 (%) 年初至报告期 末 年初至报告期末比 上年同期增减变动 幅度(%) 营业收入 96,519,541.28 2.32 298,606,173.49 2.74 利润总额 8,169,473.75 262.52 38,720,027.55 43.13 归属于上市公司股东的净利 润 7,190,825.2 ...